A detailed history of Parallel Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,977 shares of DXCM stock, worth $158,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,977
Previous 4,024 50.87%
Holding current value
$158,239
Previous $456,000 71.05%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $131,008 - $237,574
-2,047 Reduced 50.87%
1,977 $132,000
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $11,913 - $15,168
-108 Reduced 2.61%
4,024 $456,000
Q1 2024

May 06, 2024

BUY
$114.22 - $140.1 $59,965 - $73,552
525 Added 14.56%
4,132 $573,000
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $89,757 - $147,626
1,189 Added 49.17%
3,607 $447,000
Q3 2023

May 20, 2024

SELL
$86.06 - $137.93 $34,079 - $54,620
-396 Reduced 14.07%
2,418 $225,000
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $34,079 - $54,620
-396 Reduced 14.07%
2,418 $225,000
Q2 2023

May 20, 2024

BUY
$112.47 - $130.98 $7,310 - $8,513
65 Added 2.36%
2,814 $361,000
Q2 2023

Aug 04, 2023

BUY
$112.47 - $130.98 $7,310 - $8,513
65 Added 2.36%
2,814 $361,000
Q1 2023

May 20, 2024

SELL
$104.0 - $122.92 $143,832 - $169,998
-1,383 Reduced 33.47%
2,749 $319,000
Q1 2023

Apr 25, 2023

SELL
$104.0 - $122.92 $39,312 - $46,463
-378 Reduced 12.09%
2,749 $319,000
Q4 2022

Feb 03, 2023

BUY
$84.98 - $122.67 $64,924 - $93,719
764 Added 32.33%
3,127 $354,000
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $51,841 - $63,948
679 Added 40.32%
2,363 $190,000
Q2 2022

Aug 01, 2022

BUY
$67.99 - $132.89 $74,585 - $145,780
1,097 Added 186.88%
1,684 $126,000
Q1 2022

Apr 28, 2022

SELL
$94.08 - $130.2 $1,317 - $1,822
-14 Reduced 2.33%
587 $305,000
Q4 2021

Jan 20, 2022

BUY
$129.87 - $162.82 $3,246 - $4,070
25 Added 4.34%
601 $323,000
Q3 2021

Nov 02, 2021

BUY
$106.71 - $143.18 $15,046 - $20,188
141 Added 32.41%
576 $315,000
Q2 2021

Aug 06, 2021

BUY
$80.99 - $107.93 $7,046 - $9,389
87 Added 25.0%
435 $186,000
Q1 2021

Apr 23, 2021

SELL
$84.79 - $104.74 $10,005 - $12,359
-118 Reduced 25.32%
348 $125,000
Q4 2020

Feb 02, 2021

SELL
$78.0 - $104.5 $18,642 - $24,975
-239 Reduced 33.9%
466 $172,000
Q3 2020

Oct 27, 2020

BUY
$95.51 - $112.95 $37,821 - $44,728
396 Added 128.16%
705 $291,000
Q2 2020

Jul 16, 2020

SELL
$62.68 - $105.34 $2,256 - $3,792
-36 Reduced 10.43%
309 $125,000
Q1 2020

Apr 27, 2020

SELL
$47.79 - $75.63 $1,338 - $2,117
-28 Reduced 7.51%
345 $92,000
Q4 2019

Jan 30, 2020

BUY
$36.62 - $57.29 $4,833 - $7,562
132 Added 54.77%
373 $82,000
Q3 2019

Nov 01, 2019

BUY
$35.53 - $43.8 $1,065 - $1,314
30 Added 14.22%
241 $36,000
Q2 2018

Jul 30, 2018

BUY
$17.54 - $25.22 $1,280 - $1,841
73 Added 52.9%
211 $20,000
Q1 2018

May 08, 2018

BUY
$13.06 - $18.54 $352 - $500
27 Added 24.32%
138 $10,000
Q3 2017

Nov 15, 2017

BUY
$11.36 - $18.98 $1,260 - $2,106
111 New
111 $6,000
Q3 2017

Nov 14, 2017

SELL
$11.36 - $18.98 $1,113 - $1,860
-98 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
98
98 $7,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.